Politics infuses pending EU decision over glyphosate reapproval

Untitled

The European Commission stands ready to insert a clause referring to biodiversity in the glyphosate renewal proposal if it is requested by member states, a Commission Spokesperson told EURACTIV.com….

The glyphosate debate heated up in September when French Environment Minister Nicolas Hulot announced Paris would vote against the renewal of Monsanto’s weed killer.

EURACTIV asked the EU executive [Social-Democrat Sigmar Gabriel] whether it was mulling a “biodiversity clause” in the glyphosate proposal.

“So far, no member state has made a request to insert such a clause referring to biodiversity. If and when such a request is made, the Commission is, of course, ready to look into it, together with all member states in the Standing Committee,” a European Commission Spokesperson noted.

As far as the other member states are concerned, EURACTIV has learnt that the vast majority have not come to a clear conclusion.

Luxembourg, for instance, faces similar internal disagreements as Germany and may therefore abstain.

Italy is close to France on the issue while technical services in several smaller member states have greenlighted glyphosate’s re-authorisation but are still awaiting a final decision from the political leadership.

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion and analysis. Read full, original post: Commission open to ‘biodiversity clause’ to end glyphosate deadlock

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
ChatGPT-Image-May-26-2026-07_51_21-AM-2
Viewpoint: There are more than 1,000 chemicals in a cup of coffee—including many substances that can cause cancer. Why isn’t it banned?
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.